Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
seemingly-harmless's Profile
Displaying 101-150 of 306 result(s).
CYDY CytoDyn Inc
12/12/2023 9:24:14 PM
my time comin, any day now (2)
CYDY CytoDyn Inc
11/20/2023 5:29:04 PM
we have learned that the FDAs and B
CYDY CytoDyn Inc
11/18/2023 2:05:35 PM
entirely new trial request indicate (5)
CYDY CytoDyn Inc
11/18/2023 9:21:16 AM
so merck has no option but to make (3)
CYDY CytoDyn Inc
11/17/2023 7:16:07 PM
then why even bother to do the comb (4)
CYDY CytoDyn Inc
11/16/2023 10:22:39 PM
release of keytruda/LL data - when (2)
CYDY CytoDyn Inc
11/13/2023 7:13:36 PM
i am missing this also...if this dr (5)
CYDY CytoDyn Inc
11/08/2023 6:03:21 PM
reminds me to not call it a democra (11)
CYDY CytoDyn Inc
10/13/2023 2:30:00 PM
so amarex' goal to delay, obfuscate (2)
CYDY CytoDyn Inc
10/02/2023 10:10:43 PM
simple. yes on shares but a hard no (15)
CYDY CytoDyn Inc
09/28/2023 12:29:10 PM
he did it so brazenly because peopl (5)
CYDY CytoDyn Inc
08/14/2023 11:27:25 AM
biktarvy/gilead does not qualify as (5)
CYDY CytoDyn Inc
08/07/2023 12:56:15 PM
how does 23% of the group magically (1)
CYDY CytoDyn Inc
08/01/2023 4:07:43 PM
The irony of a safety hold on Leron (2)
CYDY CytoDyn Inc
07/25/2023 3:25:13 PM
article on heart disease linked to (4)
CYDY CytoDyn Inc
07/25/2023 2:46:01 PM
but that doesn't mean that Amarex w
CYDY CytoDyn Inc
07/24/2023 11:27:36 PM
if they are using litigation and ar (3)
CYDY CytoDyn Inc
07/24/2023 1:47:25 PM
yet oj simpson is still living the (1)
CYDY CytoDyn Inc
07/24/2023 1:00:30 PM
the FDA requesting new trial protoc (5)
CYDY CytoDyn Inc
07/12/2023 11:46:18 AM
clearly assures us that the FDA is (4)
CYDY CytoDyn Inc
06/30/2023 10:04:34 AM
we are all banking (literally) that (6)
CYDY CytoDyn Inc
06/19/2023 12:32:20 PM
hold was enacted because of the 2 S (4)
CYDY CytoDyn Inc
05/18/2023 11:15:13 AM
IFN-a mentioned in this video as a (2)
CYDY CytoDyn Inc
05/13/2023 3:43:27 PM
ive had sepsis in my family a few t (4)
CYDY CytoDyn Inc
05/08/2023 7:55:03 PM
a lot of "glitches" in this era of
CYDY CytoDyn Inc
05/05/2023 9:25:50 PM
yes the billing code revelation too (9)
CYDY CytoDyn Inc
04/28/2023 1:39:48 PM
"Meanwhile the FDA has a hold on a (5)
CYDY CytoDyn Inc
04/17/2023 7:04:01 PM
yes this is very confusing. this in (4)
CYDY CytoDyn Inc
04/15/2023 3:15:39 PM
agree that the future SHOULD be as (2)
CYDY CytoDyn Inc
04/13/2023 4:39:55 PM
when other currently advertised and (4)
CYDY CytoDyn Inc
04/12/2023 4:55:41 PM
the FDA is no friend Quote: It just (7)
CYDY CytoDyn Inc
04/11/2023 12:06:45 AM
get ready for items 7 and 8. yes th (3)
CYDY CytoDyn Inc
03/31/2023 11:56:58 AM
ALWAYS bring two buck chuck to blin (1)
CYDY CytoDyn Inc
03/29/2023 10:37:40 AM
the trend of CYDY telling us what a (2)
CYDY CytoDyn Inc
03/23/2023 9:06:52 PM
shes going to find out when the new (1)
CYDY CytoDyn Inc
03/23/2023 8:54:13 PM
ok there you go, patterson was not (1)
CYDY CytoDyn Inc
03/23/2023 8:17:56 PM
jesus no im not wingnut yo. im just (3)
CYDY CytoDyn Inc
03/23/2023 7:42:45 PM
first off, since when is business f (3)
CYDY CytoDyn Inc
03/22/2023 11:36:53 PM
part of his story is that he had th (10)
CYDY CytoDyn Inc
03/11/2023 9:08:34 PM
the problem for us lay people is : (2)
CYDY CytoDyn Inc
03/09/2023 1:11:05 PM
remdesivir a drug that barely does (3)
CYDY CytoDyn Inc
03/05/2023 9:03:54 PM
the FDA is completely making stuff (5)
CYDY CytoDyn Inc
03/03/2023 6:26:36 PM
like i said, cartel heroin dealers (1)
CYDY CytoDyn Inc
02/28/2023 11:38:32 AM
rear mirror? hardly...long covid is (13)
CYDY CytoDyn Inc
02/27/2023 1:30:10 PM
"its the paperwork thats killing pe (3)
CYDY CytoDyn Inc
12/28/2022 10:44:06 PM
precisely my thinking...the only re
CYDY CytoDyn Inc
12/28/2022 8:23:19 PM
absolute and complete total fraud a (2)
CYDY CytoDyn Inc
12/26/2022 1:56:27 PM
agree and if laws were blatantly br (5)
CYDY CytoDyn Inc
12/25/2022 7:56:00 PM
the SEC and DOJ are pressing on nad (11)
CYDY CytoDyn Inc
12/23/2022 8:23:09 PM
the FDA are mostly in the business (3)
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • Tronox Holdings: Key Update on Class Action Lawsuit
  • BlackRock Canada Updates iShares Premium Money Market ETF Payout
  • Volatus Aerospace Enhances Defense With New UAS Acquisition
  • How a Decade of Investing in Cameco Can Transform Your Wealth
  • Volatus Aerospace Enhances Capabilities with Innovative UAS Acquisition
  • Analyzing Ingersoll Rand's P/E Ratio and Market Trends
  • Final Cash Distributions for iShares Premium Money Market ETF
  • Volaris Posts Q3 2025 Results: Insights on Growth and Challenges
  • Innovative Partnership to Transform Rent Payments with Venmo
  • Gold Port Corporation Boosts Exploration with Private Placement
  • Investigation of Athena Technology Acquisition Corp. II Ongoing
  • Class Action Investigation of Plymouth Industrial REIT, Inc.
  • Volaris Achieves Resilient Q3 Performance Despite Challenges
  • Sotherly Hotels Inc. Faces Legal Scrutiny Under Proposed Sale Terms
  • Southwest Airlines Unveils Major Notes Offering and Plans
  • James Hardie Industries Targeted in Securities Fraud Lawsuit
  • Insightful Analysis on Taiwan Semiconductor and Campbell's Stocks
  • Venmo and Bilt Transform Rental Payments with Innovative Partnership
  • Empowering Leadership: Celebrating Women at Mainscape
  • Pursuing Justice: WPP plc Investors' Class Action Pathway
  • ETHZilla Corp Boosts Stock Value by Selling Ethereum Holdings
  • Leadership Changes at Vestand: New CFO and CCO Appointments
  • Investors Rally: Class Action Filed Against James Hardie
  • Conduent Cybersecurity Incident: Impacts and Legal Actions
  • Discover the Exceptional Growth of Eaton Corp Stock Over 5 Years
  • Vestand Welcomes New Leadership: Jaeho Yoon and Andrew Yun
  • NOV Inc.'s Q3 2025 Performance and Board Appointment Insights
  • Zenni Optical Unveils EyeQLenz™: A New Era in Eyewear Innovation
  • First Horizon Unveils Major Stock Repurchase and Dividend Plans
  • ArcelorMittal Releases Third Quarter 2025 Analyst Consensus
  • Investors Should Act Now: Class Action Lawsuits Involving BAX, FLYYQ, and MOH
  • Amazon's Historic Workforce Reductions: What's Next for AMZN?
  • Class Action Against MoonLake: What Investors Need to Know
  • Ferrellgas Secures Financial Flexibility Through Senior Notes Deal
  • NOV Reports Q3 2025 Performance Boost and New Board Member
  • Eos Energy Enterprises to Share Q3 2025 Financial Results
  • Important Updates for Fluor Corporation Investors Ahead of Legal Actions
  • Magnera Set to Announce Fourth Quarter Fiscal Results Soon
  • Legal Guidance for Baxter International Investors Ahead of Deadline
  • Anteris Technologies Starts Enrollment in Innovative Heart Valve Trial
  • How $100 Invested in American Express Grows Over 5 Years
  • Strategic Moves by PL Capital Towards Horizon Bancorp’s Future
  • Magnera Corporation to Announce Q4 and FY2025 Results Soon
  • Northern Virginia Housing Trends: Surging Sales and Inventory Growth
  • Scenic Sotheby's Realty Expands Services with New Office
  • Northern Virginia Housing Market Surges with Positive Trends
  • Scenic Sotheby's International Realty Expands in Gulf Coast Market
  • Exploring Enzon Pharmaceuticals' Merger with Viskase Companies
  • Investigation Launched into Athena Technology Acquisition Corp. II
  • Emerging Therapies Transform Basal Cell Nevus Syndrome Landscape
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site